PVI
FOMX

Pura Vida Investments’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Pura Vida Investments’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,900
Closed -$94K – 107
2017
Q1 		$94K Buy
+18,900
New +$182K 0.03% 77

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Pura Vida Investments's FOMX Position: Q3 2018 in Review

Pura Vida Investments sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2018, closing a stake of 24,100 shares — an estimated $121K sold.

Pura Vida Investments first reported a position in FOMX in Q3 2015 and held it in 12 quarters. The position peaked at $1.52M in Q4 2016. 75 funds tracked by Wall St. Rank hold FOMX as of Q3 2018.

  • Pura Vida Investments reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2018 after selling out during the quarter.
  • Pura Vida Investments sold 24,100 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2018, an estimated $121K.
  • Pura Vida Investments first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2015 and held it in 12 quarters.
  • Pura Vida Investments's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.52M in Q4 2016.
  • 75 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2018.

Based on Pura Vida Investments's 13F filing for Q3 2018, filed 14 Nov 2018.